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Supplemental experimental procedures 
Reagents. 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1-palmitoyl-2-oleoyl-sn-glycero-
3-phosphocholine (POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE), 
1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS), and palmitoyl-Coenzyme A (ammonium 
salt) (16:0) were purchased from Avanti Polar Lipids. 1,2-Diacyl-sn-glycero-3-phospho-(1-D-
myo-inositol) (PI), n-octyl-β-D-glucopyranoside (OGP), TX-100, 5,5'-dithiobis-(2-nitrobenzoic 
acid) (≥98%) (DTNB, Elman’s reagent), sn-Glycerol 3-phosphate bis(cyclohexylammonium) 
salt (G3P), bovine serum albumin BSA, Acyl-Coenzyme A synthetase from Pseudomonas sp. 
(A3352), and inorganic Pyrophosphatase from baker's yeast (I1891) were acquired from Sigma-
Aldrich. Alkaline phosphatase from bovine intestinal mucosa (79385), calcein (21030), 
Adenosine 5′-triphosphate disodium salt hydrate (ATP), 1-butanol (n-butanol) and hexane were 
purchased from Fluka. Bio-Beads SM-2 were acquired from Bio-Rad. Ni-NTA Agarose was 
purchased from QIAGEN. Q Sepharose Fast Flow was acquired from GE Healthcare. TCEP 
(11303) was purchased from CovaChem, USA. α-dodecyl-ω-hydroxy-poly(oxy-1,2-ethanediyl 
oxy-1,2- ethanediyl) (C12E9) was acquired from Affymetrix, USA. [3H]palmitic acid [9,10-
3H(N)] (10 mCi/ml; 60 Ci/mmol) was purchased from ANAWA Trading SA, Wangen, 
Switzerland. Coenzyme A trilithium salt (CoA; 234101) and 1,2-dichloroethane were acquired 
from Merck. Silica gel 20 x 20 cm TLC plates were obtained from Macherey-Nagel, 
Switzerland. LabAssay Phospholipid (296-63801) to measure PC was from Wako, Japan. 
Cloning, expression and purification of sqGPAT. The coding region of the chloroplast GPAT of 
squash (sqGPAT) was amplified by PCR directed by the oligonucleotides sqGPAT-forward (5'- 
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GGC AGC CAT ATG GCT AGC CAC TCC CGC AAA TTT CTC -3') and sqGPAT-reverse 
(5’- AGC AGC CGG ATC CTC GAG CTA CCA AGG TTG TGA CAA AGA G -3’) using 
cDNA from Cucurbita moschata (SQ1AT cDNA (AT03) in pTZ18R as the template. The PCR 
product was cleaved with NdeI and XhoI, and inserted into a precleaved T7-promoter-based 
expression vector, pET15b, providing a His6-tag at the N-terminus. The correct construction of 
the plasmid was verified by nucleotide sequencing. sqGPAT was overexpressed in the E. coli 
BL21(DE3) strain (Novagen, USA). A 50 mL sample of overnight culture was used to inoculate 
2 L of Luria–Bertani medium containing 100 µg/ml of ampicillin. Expression of sqGPAT was 
induced at an OD600 of approximately 0.8 by adding isopropyl thio-β-D-galactoside to a final 
concentration of 1 mM. Cells were grown for an additional 5 h at 30 °C, centrifuged and frozen 
at -20 °C. Six g of frozen cells, was thawed into 50 mL buffer A (20 mM potassium phosphate, 
pH 8, 300 mM NaCl, 10% glycerol) supplemented with 1 mM TCEP, 1 mg/ml of lysozyme, 10 
µg/ml of DNase, 20 µg/ml of RNase and 1x Roche protease inhibitor cocktail (EDTA-free). The 
cells were incubated on ice for 45 min with occasional vigorous shaking, and extracted by 
passing 5 times through the ice-precooled Microfluidizer M-110L (Microfluidics). Broken cells 
were centrifuged (30 min, 4 °C, 15 000 g). Supernatant was applied to a 2-mL Ni-NTA gravity 
column (QIAGEN), which had been equilibrated with buffer A containing 10 mM imidazole. 
Unbound proteins were eluted with the above buffer and the bound sqGPAT was eluted with 
buffer A containing 300 mM imidazole. The protein was dialyzed two times against 3 L of 
buffer B (20 mM potassium phosphate, pH 8, 50 mM NaCl) at 4 °C. The dialyzed sample was 
applied to a 1-ml ion-exchange Q Sepharose Fast Flow column (GE Healthcare) equilibrated 
with buffer B. Bound sqGPAT was eluted from the column by a linear gradient of NaCl in 
buffer B up to 1 M NaCl. Fractions shown to contain sqGPAT by SDS-PAGE (12% gels) and 
Coomassie blue staining were pooled and stored at -80 °C in buffer B.  
Cloning, expression and purification of PFO. The coding region for the Cho binding 
perfringolysin O (PFO) from Clostridium perfringens without the signal sequence was amplified 
by PCR using the oligonucleotides PFO-forward (5’-
GCGGATCCAAGGATATAACAGATAAAAATCAAAGTAT-3’) and PFO-reverse (5’- CGC 
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ACG CGT TTA ATT GTA AGT AAT ACT AGA TCC AGG-3’). The PCR product was 
cleaved with BamHI and MluI, and inserted into a precleaved, T7-promoter-based expression 
vector that leaves a His6-tag with a thrombin-recognition sequence at the N-terminus [32]. The 
correct construction of the plasmid was verified by nucleotide sequencing. PFO was 
overexpressed in the E. coli BL21(DE3) strain and purified using exactly the same protocol as 
for sqGPAT except that only 0.5 mM thio-β-D-galactoside were used. 
Colorimetric assay for sqGPAT activity. Enzymatic activity of sqGPAT was determined by 
colorimetric measurements at 412 nm [33]. The reaction was carried out at RT in buffer D 
containing 1 mM 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB, Elman’s reagent) in a 
spectrometric cuvette. Assays contained 2 µg (46 pmol) of sqGPAT, 1 mM G3P and 1-20 µM 
palmitoyl-CoA in a final volume of 1 ml. Note that the critical micelle concentration (CMC) of 
palmitoyl-CoA under similar conditions is 75 µM [26]. Equimolar concentrations of BSA were 
added to insure solubility of palmitoyl-CoA. Reagents were added into the cuvette in the order: 
BSA, liposomes or detergent, sqGPAT, G3P, palmitoyl-CoA (dissolved in water).  
Synthesis of [3H]palmitoyl-CoA. [3H]palmitoyl-CoA was synthesized adapting published 
methods [34, 35] in 1 ml of buffer C (50 mM Tris pH 7.5, 10 mM MgCl2, 0.1 mM EGTA, 1 mM 
DTT, 10 mM ATP, 10 mM CoA, 1.7 mM (0.1%) Triton X-100) containing 0.1 U Acyl-
Coenzyme A synthetase, 1 U Pyrophosphatase and 40 nmol (2.4 mCi) [3H]palmitic acid. For 
this, [3H]palmitic acid was gently dried under a flow of N2 in a glass tube. 1 ml of buffer C 
containing the enzymes was added. After vigorously vortexing for 2 min the tube was left 3 h at 
room temperature (RT). [3H]palmitoyl-CoA was extracted 5 times with 1 ml water saturated 
butanol (1:1, v/v) and dried in a rotary evaporator (SpeedVac). The dried material was 
resuspended in 1 ml of water-saturated 1,2-dichloroethane by vortexing; 1 ml of 1,2-
dichloroethane-saturated water was added and the sample again vortexed vigourosly. 
Dichloroethane extracts free [3H]palmitic acid and TX-100, whereas [3H]palmitoyl-CoA remains 
in the water phase. The sample was then centrifuged at 5000g for 5 min. The (lower) 
dichloroethane phase was carefully discarded by a Pasteur pipette. The water phase containing 
[3H]palmitoyl-CoA was extracted four more times with water-saturated dichloroethane. Finally, 
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[3H]palmitoyl-CoA was removed from the water phase by adding 1 ml water saturated 1-butanol 
and the butanol phase was dried under the vacuum. The dried material was finally resuspended 
in 4 ml of chloroform-methanol-water 80:20:2 or water-saturated butanol by intensive vortexing 
and stored at -20°C. The typical yield of [3H]palmitoyl-CoA was around 50 % in terms of the 
[3H]palmitate added in the beginning.  
Colorimetric assay for sqGPAT activity. Enzymatic activity of sqGPAT was determined 
utilizing a spectrophotometer Cecile CE1010 (Cecile Instruments) and measuring the absorption 
at 412 nm. Reaction were carried out in buffer 1 ml of D containing 1 mM 5,5'-dithiobis-(2-
nitrobenzoic acid) (DTNB). The sqGPAT concentration in the cuvette was 2 µg/ml. Normally, 
concentrations of substrates were 1 mM G3P and 1-20 µM palmitoyl-CoA. Equimolar 
concentrations of BSA were added to insure palmitoyl-CoA solubility and accessibility. 
Reagents were added into the cuvette in the order: Buffer, BSA, liposomes or detergent, 
sqGPAT, G3P, palmitoyl-CoA, respectively. Reactions were allowed to take place at RT. 
Calcein release. Large unilamellar vesicles (LUVs) containing calcein were prepared by freeze 
thawing and extrusion of multilamellar vesicles as described [27]. Briefly, 2.1 µmol of DOPC 
and 0.9 µmol of Cho (70:30 mol%) in chloroform were mixed and dried in a 30 ml Pyrex round-
bottom glass tube in a rotary evaporator under vacuum for 3 h. The lipid film was resuspended 
in 1 ml of 60 mM calcein in buffer D and vigorously vortexed in the presence of glass beads for 
2 min, yielding multilamellar vesicles (MLV). MLVs were then frozen and thawed repeatedly 
(six times) by shifting from liquid N2 to a water bath at 37°C. Then, MLVs were extruded 
through polycarbonate membranes with 100 nm pores by an Avestin lipid extruder (Avestin, 
Ottawa, ON) to yield LUVs with 100 nm in diameter [36]. The excess of calcein was removed 
by gel filtration on a small G-50 column. The concentration of PC was determined by an 
enzymatic test based on the choline oxidase/DAOS method [24]. Permeabilization of calcein-
loaded LUVs was assessed by using a fluorescence reader. For this, LUVs representing 5 nmol 
of DOPC/Cho (70:30 mol%) were added into 1 ml of buffer D and placed in a fluorimetric 
cuvette under constant magnetic stirring. Repeated additions of palmitoyl-CoA were made. The 
excitation and emission filters were set to 485 and 535 nm, respectively. The permeabilization 
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induced by palmitoyl-CoA was compared to the maximal permeabilization obtained at the end 
of the assay by the addition of detergent TX-100 to a final concentration of 2 mM. 
 
 
Figure S1. Sequential steps of sqGPAT encapsulation into LUV. A, different stages, 
at which samples were taken for SDS-PAGE. Prot. K, proteinase K.  
B, SDS-PAGE and Coomassie staining of samples taken at different stages during 
liposomes preparation. Lane 1, starting material before removal of detergent; lane 2, 
liposomes after complete removal of detergent with SM-2 beads; lane 3, liposomes 
after proteinase K treatment for 1 h at 4°C; lane 4, liposomes after proteinase K 
treatment for 1 h at 4°C in presence of OGP; lanes 5 and 6, 1 µg and 2 µg of 
sqGPAT for comparison. C, lanes as in panel A, but liposomes were treated with 50 
µg of trypsine. 
 
250 
 
130 
 
100 
 
70 
 
55 
 
 
 
35 
 
 
25 
Prot. K 
+OGP 
1 µg Prot. K	   2 µg 
MW 
kDa 1 2 3 5 6 4 
Starting  
material = 1 
SM-2 beads Non-treated 
liposomes = 2  
Prot. K 
 treated 
liposomes = 3  
Prot. K 
+ OGP treated 
liposomes = 4  
Trypsine 
+OGP 
1 µg Trypsine	   2 µg 
250 
 
130 
 
100 
 
70 
 
55 
 
 
 
35 
 
 
25 
15 
1 2 3 5 6 4 
A	  
MW 
kDa 
C	  
B	  
Figure S1 
0.000 
0.020 
0.040 
0.060 
0.080 
0.100 
0.120 
0.140 
0.160 
0.180 
0.200 
0.0 1.0 2.0 3.0 4.0 5.0 
A
bs
 (4
12
 n
m
) 
Time (min) 
20 µM LUV 
50 µM LUV 
100 µM LUV 
150 µM LUV 
150 µM LUV / no sqGPAT 
10 µM BSA 
B 
A 
0.000 
0.020 
0.040 
0.060 
0.080 
0.100 
0.120 
0.140 
0.160 
0.180 
0.200 
0.0 1.0 2.0 3.0 4.0 5.0 
A
bs
 (4
12
 n
m
) 
Time (min) 
BSA 
BSA + palmitoyl-CoA  
BSA + G3P 
BSA + palmitoyl-CoA + G3P / no 
sqGPAT 
BSA + palmitoyl-CoA + G3P 
palmitoyl-CoA + G3P 
Figure	  S2.	  Eﬀect	  of	  the	  addi4on	  of	  BSA	  or	  liposomes	  on	  sqGPAT	  enzyma4c	  ac4vity	  in	  solu4on.	  A	  and	  B,	  
reac,ons	  were	  carried	  out	  in	  1	  ml	  of	  buﬀer	  D	  with	  1	  mM	  DTNB.	  Reagents	  were	  added	  in	  the	  order:	  10	  
µM	  BSA	  (panel	  A)	  or	  LUVs	  (panel	  B)	  equivalent	  to	  20	  -­‐	  150	  µM	  of	  DOPC,	  2	  µg	  sqGPAT,	  G3P	  (to	  1	  mM),	  
and	  palmitoyl-­‐CoA	  (to	  10	  μM).	  For	  this	  experiment,	  LUVs	  were	  made	  by	  extrusion	  (without	  using	  
detergent).	  A	  10	  µM	  solu,on	  of	  CoA	  also	  gave	  an	  absorbance	  of	  about	  0.2,	  indica,ng	  that	  the	  reac,on	  
with	  BSA	  goes	  to	  comple,on.	  The	  experiment	  was	  repeated	  once	  and	  gave	  the	  same	  result.	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Figure	  S3.	  Permeabilisa4on	  of	  calcein-­‐loaded	  LUVs	  by	  palmitoyl-­‐CoA.	  
Calcein	  containing	  liposomes	  equivalent	  to	  5	  nmol	  of	  DOPC	  in	  1	  ml	  of	  
buﬀer	  D	  were	  placed	  in	  a	  photometric	  cuveXe	  and	  kept	  under	  constant	  
s,rring	  at	  25°C.	  At	  various	  ,mes,	  the	  indicated	  amounts	  of	  palmitoyl-­‐CoA	  
and	  TX-­‐100	  were	  added	  from	  20	  µM	  and	  20%	  (v/v)	  stock	  solu,ons.	  
Fluorescence	  was	  followed	  by	  using	  an	  excita,on	  wavelength	  of	  485	  nm	  
and	  measuring	  the	  emission	  at	  520	  nm.	  TX-­‐100	  does	  not	  absorb/emit	  or	  
signiﬁcantly	  disperse	  at	  these	  wave	  lengths	  and	  concentra,on.	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Figure	  S4.	  Phosphatase	  treatment	  
of	  [3H]palmitoyl-­‐CoA	  in	  the	  
absence	  of	  liposomes.	  A,	  lanes	  1	  -­‐	  
5:	  [3H]palmitoyl-­‐CoA	  (17	  pmol)	  
was	  treated	  with	  bovine	  alkaline	  
phosphatase	  (AP,	  100	  U)	  or	  λ 
phosphatase	  (400	  U)	  at	  30°C	  for	  1	  
h	  at	  pH	  7.5.	  Lanes	  6	  –	  13,	  
[3H]palmitoyl-­‐CoA	  was	  treated	  
with	  10	  or	  100	  U	  AP	  for	  0	  to	  10	  
min	  at	  RT	  and	  pH	  7.0.	  Products	  
were	  analyzed	  by	  TLC	  and	  
radioscanning	  as	  in	  Fig.	  3.	  B,	  and	  
C:	  Forma,on	  of	  dephospho-­‐
[3H]palmitoyl-­‐CoA	  by	  phosphatase	  
treatment	  in	  20	  mM	  phosphate	  
buﬀer	  with	  various	  concentra,ons	  
of	  AP,	  at	  various	  pH	  (pH	  7	  or	  7.5)	  
and	  temperatures	  (RT	  or	  30°C).	  
Panels	  B	  and	  C	  plot	  the	  data	  of	  Fig.	  
3B,	  S4A	  (lanes	  6	  –	  13)	  and	  an	  
addi,onal	  experiment.	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Figure	  S5.	  Phosphatase	  treatment	  of	  large	  unilamellar	  vesicles	  of	  diﬀerent	  composi4on	  
containing	  [3H]palmitoyl-­‐CoA.	  The	  same	  LUVs	  as	  used	  for	  Fig.	  2	  (100	  nmol	  of	  DOPC,	  
POPC,	  POPC/POPE,	  POPC/POPE	  /DOPS/PI)	  containing	  [3H]palmitoyl-­‐CoA	  (17	  pmol)	  were	  
diluted	  into	  1	  ml	  of	  buﬀer	  D	  (pH	  7.0)	  containing	  10	  U	  of	  AP	  and	  incubated	  at	  RT	  for	  
indicated	  ,mes	  (min).	  The	  frac,on	  of	  dephospho-­‐palmitoyl-­‐CoA	  was	  determined	  by	  
TLC/radioscanning	  and	  calculated	  as	  percentage	  of	  total	  radioac,vity	  per	  lane.	  	  
Note	  that	  the	  use	  of	  TX-­‐100	  is	  not	  op,mal	  for	  AP,	  always	  resul,ng	  in	  lower	  values	  for	  
maximal	  cleavage	  than	  OGP	  (Fig.	  3C).	  For	  comparison,	  the	  %	  of	  LPA	  generated	  by	  
sqGPAT	  using	  the	  same	  liposomes	  (Fig.	  2)	  are	  added	  in	  red.	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Figure	  S6.	  Phosphatase	  treatment	  of	  large	  unilamellar	  vesicles	  containing	  cholesterol	  or	  
ergosterol	  and	  [3H]palmitoyl-­‐CoA.	  LUVs	  (100	  nmol	  of	  DOPC/Cholesterol	  (70:30	  mol%),	  
or	  DOPC/Ergosterol	  (70:30	  mol%))	  containing	  [3H]palmitoyl-­‐CoA	  (17	  pmol)	  were	  treated	  
with	  10	  U	  of	  alkaline	  phosphatase	  at	  pH	  7.0	  and	  RT.	  Reac,ons	  were	  incubated	  for	  
indicated	  ,mes	  (min).	  The	  amount	  of	  dephospho-­‐Palmitoyl-­‐CoA	  formed	  is	  indicated	  as	  
%	  dephospho-­‐palmitoyl-­‐CoA/[palmitoly-­‐CoA	  +	  dephospho-­‐palmitoyl-­‐CoA].	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